Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516333 · ClinicalTrials.gov registry record · Phase 1
Replace Glycemic Load and Satiety Study
A Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT01516333 is a Phase 1 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 26 participants.
The verdict
NCT01516333, a Phase 1 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The study is to examine the effect of four diets differing in glycemic index and amount of carbohydrate on blood sugar and insulin and in hunger, satiety, and vigor.
Interventions
- OTHER High GL 107
- OTHER Medium GL 76
- OTHER Medium GL 68
- OTHER Low GL 48
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2007-02 |
| Est. Completion | 2007-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01516333
The ClinicalTrials.gov registry entry for NCT01516333 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which High GL 107 is the first listed.
NCT01516333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01516333 about?
NCT01516333 is a clinical study titled "Replace Glycemic Load and Satiety Study". The study is to examine the effect of four diets differing in glycemic index and amount of carbohydrate on blood sugar and insulin and in hunger, satiety, and vigor.
What is the current status of trial NCT01516333?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2007-02. Estimated completion is 2007-06.
What interventions are being tested in trial NCT01516333?
The interventions under investigation include: High GL 107 (OTHER), Medium GL 76 (OTHER), Medium GL 68 (OTHER), Low GL 48 (OTHER).
Who is sponsoring clinical trial NCT01516333?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.